Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tablets for tots: could eHealth revolutionize home care for sick children?

NCT ID NCT04150120

Knowledge-focused Sponsor: Lund University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested whether giving families of children with long-term illnesses (like cancer, heart disease, or premature birth) a tablet computer with a special app helps them manage care at home. Researchers measured satisfaction, cost-effectiveness, and how well families followed treatment plans. The goal was to see if eHealth can improve communication with hospital staff and support self-management.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
e-health device with application
What this could lead to
If successful, this could show that eHealth tools improve family self-management and reduce hospital visits for children with long-term illnesses.
What could go wrong
This is an observational study with no treatment being tested, so it won't directly cure or change the course of any disease. Results may not apply to all families or healthcare systems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

720 people

The number who actually took part.

Started

Oct 2019

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 days to 19 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (Intervention group): Legal guardians of children below four years of age who are hospitalised for: * reconstructive surgery for congenital malformations * cardiac surgery for CHD * premature birth * paediatric cancer and in treatment * are in need of nutritional supplements * are about to be discharged from the hospital * are able to communicate in the local language (Swedish in Sweden and Danish in Denmark) * signs informed consent For the Ethiopian arm: Adolescents, aged 15-19, living with HIV and currently enrolled in ART care for two years or less, being able to read the local language and willing to participate in the study will be eligible for the study. Inclusion Criteria (Control group): Legal guardians of children below four years of age who fulfil the intervention group inclusion criteria but: * do not want to use the e-device * not recruited for the intervention group * are recruited after the stipulated numbers for the intervention group are met For the Ethiopian arm: Adolescents, aged 15-19, living with HIV and currently enrolled in ART care for two years or less, being able to read the local language and willing to participate in the study will be eligible for the study. Exclusion Criteria: * Legal guardians of children fulfilling the inclusion criteria but where the child has complications or comorbidity which may affect the results of the study (as defined by the responsible medical physician) * The legal guardian refuses to sign informed consent. For the Ethiopian arm: Patients outside of the specified age and adolescents, who are in patient-department, and adolescents who cannot read.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence, patient are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS Child Nutrition Disorders childhood malignant neoplasm Congenital Abnormalities congenital heart disease developmental defect during embryogenesis Hirschsprung disease HIV infectious disease neoplasm nutritional disorder Patient Compliance Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence, patient Congenital heart disease Congenital malformation Hirschsprung disease HIV Nutrition disorder, child Pediatric cancer Preterm birth

Contacts and locations

Locations

  • Arba Minch University

    Arba Minch, Southern Nations, Nationalities, and Peoples' Region, Ethiopia

  • Hillerød Hospital

    Hillerød, Denmark

  • Neonatal Department, Skåne University Hospital

    Lund, Skåne County, Sweden

  • Paediatric Cardiology Department, Skåne University Hospital

    Lund, Skåne County, Sweden

  • Paediatric Oncology Department, Skåne University Hospital

    Lund, Skåne County, Sweden

  • Paediatric Surgery Department, Skåne University Hospital

    Lund, Skåne County, Sweden

  • Rigshospitalet

    Copenhagen, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.